{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:29:54Z","timestamp":1790335794302,"version":"4.1.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cummins Laboratory"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBMR Plus"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:label\/><jats:p>Glucocorticoids (GCs) have unparalleled anti\u2010inflammatory and immunosuppressive properties, which accounts for their widespread prescription and use. Unfortunately, a limitation to GC therapy is a wide range of negative side effects including Cushing's syndrome, a disease characterized by metabolic abnormalities including muscle wasting and osteoporosis. GC\u2010induced osteoporosis occurs in 30% to 50% of patients on GC therapy and thus, represents an important area of study. Herein, we characterize the molecular and physiologic effects of GC\u2010induced osteoporosis using the Cushing's mouse model, the corticotropin releasing hormone (CRH) transgenic mouse (CRH\u2010Tg). The humeri, femurs, and tibias from wild\u2010type (WT) and CRH\u2010Tg male mice, aged 13 to 14 weeks old were subjected to multiple bone tests including, micro\u2013computed tomography (\u03bcCT), static and dynamic histomorphometry, strength testing, and gene expression analyses. The CRH\u2010Tg mice had a 38% decrease in cortical bone area, a 35% decrease in cortical thickness, a 16% decrease in trabecular thickness, a sixfold increase in bone adiposity, a 27% reduction in osteoid width, a 75% increase in bone\u2010resorbing osteoclast number\/bone surface, a 34% decrease in bone formation rate, and a 40% decrease in bone strength compared to WT mice. At the gene expression level, CRH\u2010Tg bone showed significantly increased osteoclast markers and decreased osteoblast markers, whereas CRH\u2010Tg muscle had increased muscle atrophy gene markers compared to WT mice. Overall, the CRH\u2010Tg mouse model aged to 14 weeks recapitulated many features of osteoporosis in Cushing's syndrome and thus, represents a useful model to study GC\u2010induced osteoporosis and interventions that target the effects of GCs on the skeleton. \u00a9 2017 The Authors. <jats:italic>JBMR Plus<\/jats:italic> is published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jbm4.10009","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T10:34:04Z","timestamp":1496226844000},"page":"46-57","source":"Crossref","is-referenced-by-count":7,"title":["The CRH\u2010Transgenic Cushingoid Mouse Is a Model of Glucocorticoid\u2010Induced Osteoporosis"],"prefix":"10.1093","volume":"1","author":[{"given":"Jasmine","family":"Williams\u2010Dautovich","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keertika","family":"Yogendirarajah","sequence":"additional","affiliation":[{"name":"Lunenfeld\u2010Tanenbaum Research Institute Mount Sinai Hospital Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Dela Cruz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rucha","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D","family":"Grynpas","sequence":"additional","affiliation":[{"name":"Lunenfeld\u2010Tanenbaum Research Institute Mount Sinai Hospital Toronto Ontario Canada"},{"name":"Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L","family":"Cummins","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22346"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0173-y"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32833a5107"},{"key":"e_1_2_7_5_1","first-page":"281","article-title":"Cushing's syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma ST","year":"2015","journal-title":"Clin Epidemiol"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1997.1080"},{"key":"e_1_2_7_7_1","doi-asserted-by":"crossref","unstructured":"ShiX\u2010M ChutkanN HamrickMW IsalesCM. Mechanism of glucocorticoid\u2010induced osteoporosis: an update. In: Xiaoxiao Qian X editor. Glucocorticoids \u2010 new recognition of our familiar friend. Rijeka Croatia: In Tech; 2012. DOI:10.5772\/53978. Available from:https:\/\/www.intechopen.com\/books\/glucocorticoids-new-recognition-of-our-familiar-friend\/mechanism-of-glucocorticoid-induced-osteoporosis-an-update.","DOI":"10.5772\/53978"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3200-4"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.14.24"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0394-0"},{"issue":"5","key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/JBMR.041230","article-title":"Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men\u2014the MINOS study","volume":"20","author":"Szulc P","year":"2005","journal-title":"J Bone Miner Res"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.259"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348804"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001980170115"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12812"},{"issue":"6","key":"e_1_2_7_16_1","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1210\/endo.130.6.1597149","article-title":"Development of Cushing's syndrome in corticotropin\u2010releasing factor transgenic mice","volume":"130","author":"Stenzel\u2010Poore M","year":"1992","journal-title":"Endocrinology"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00154.2012"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1805"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.02.025"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00204.2014"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.2.691"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(01)00386-2"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K09E-038"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-370"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-005-1051-2"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0070"},{"issue":"3","key":"e_1_2_7_27_1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0889-8529(18)30090-2","article-title":"Glucocorticoids and osteoporosis","volume":"23","author":"Adler RA","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"e_1_2_7_28_1","first-page":"1863","article-title":"Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome","volume":"83","author":"Chiodini I","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-0459"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.113"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02067"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2799"},{"issue":"3","key":"e_1_2_7_33_1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1359\/JBMR.041233","article-title":"Influence of glucocorticoids on human osteoclast generation and activity","volume":"20","author":"Sivagurunathan S","year":"2005","journal-title":"J Bone Miner Res"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.08.024"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28084"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1688"},{"issue":"10","key":"e_1_2_7_37_1","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid\u2010induced osteoporosis","volume":"140","author":"Hofbauer LC","year":"1999","journal-title":"Endocrinology"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24445"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21414"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0717"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000061073"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1410126"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68699-6"},{"issue":"216","key":"e_1_2_7_44_1","first-page":"171","article-title":"Multiple pathologic fractures of the appendicular skeleton in a patient with Cushing's disease","author":"Kaplan FS","year":"1987","journal-title":"Clin Orthop Relat Res"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100107"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1996.tb15110.x"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.6.8808"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.172.4.10587135"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micron.2005.07.009"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.03.028"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00334491"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.02.005"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2869"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep36513"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2014.47"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12189"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-0978-y"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbm4.10009","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jbm4.10009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:53:04Z","timestamp":1710424384000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/1\/1\/46-57\/7478726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1002\/jbm4.10009"],"URL":"https:\/\/doi.org\/10.1002\/jbm4.10009","archive":["Portico"],"relation":{},"ISSN":["2473-4039","2473-4039"],"issn-type":[{"value":"2473-4039","type":"print"},{"value":"2473-4039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}